Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 5/20 | 0.61 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.61 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.61 |
| ▸ | LTA4H | P09960 | 7/20 | 0.58 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.58 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.54 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8890454 | 0.96 | FFAR1 (0.59) | FFAR1FFAR4ALOX5LTA4HEPHX2 | |
| SCHEMBL8888760 | 0.95 | FFAR1 (0.58) | FFAR1FFAR4ALOX5LTA4HEPHX2 | |
| SCHEMBL8890073 | 0.95 | FFAR1 (0.58) | FFAR1FFAR4ALOX5LTA4HEPHX2 | |
| SCHEMBL8887581 | 0.95 | FFAR1 (0.58) | FFAR1FFAR4ALOX5LTA4HEPHX2 | |
| SCHEMBL3091164 | 0.92 | FFAR1 (0.68) | FFAR1FFAR4ALOX5LTA4HNR1H4 | |
| SCHEMBL7907176 | 0.90 | FFAR1 (0.66) | FFAR1FFAR4ALOX5LTA4HEPHX2 | |
| SCHEMBL6338423 | 0.89 | LTA4H (0.64) | LTA4HNR1H4LMNAL3MBTL1ALDH1A1 | |
| SCHEMBL1115103 | 0.88 | LTA4H (0.65) | LTA4HNR1H4LMNAL3MBTL1ALDH1A1 | |
| SCHEMBL2773462 | 0.87 | FFAR1 (0.68) | FFAR1FFAR4ALOX5NR1H4LMNA | |
| SCHEMBL12064833 | 0.87 | ALOX5 (0.72) | ALOX5LTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11773077-B2 | Compounds containing carbon-carbon linker as GPR120 agonists | Piramal Enterprises Limited (IN) | 2023-10-03 | — | — | US | disclosed |
| US-10941133-B2 | Compounds containing carbon-carbon linker as GPR120 agonists | Piramal Enterprises Limited (IN) | 2021-03-09 | — | — | US | disclosed |
| US-20210053938-A1 | COMPOUNDS CONTAINING CARBON-CARBON LINKER AS GPR120 AGONISTS | Piramal Enterprises Limited (IN) | 2021-02-25 | — | — | US | disclosed |
| US-20180030031-A1 | COMPOUNDS CONTAINING CARBON-CARBON LINKER AS GPR120 AGONISTS | Piramal Enterprises Limited (IN) | 2018-02-01 | — | — | US | disclosed |
| CN-1349990-A | Heterocyclic compound, its preparation and use | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2002-05-22 | — | — | CN | disclosed |
| CN-1077107-C | Heterocyclic compounds, their preparation and use | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2002-01-02 | — | — | CN | disclosed |
| CN-1223653-A | Heterocyclic compounds, their preparation and use | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1999-07-21 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11773077-B2 | Compounds containing carbon-carbon linker as GPR120 agonists | GPR180, GPR68, GPR88 | FFAR1 20/4885FFAR4 42/4885ALOX5 1326/4885 |
| US-20180030031-A1 | COMPOUNDS CONTAINING CARBON-CARBON LINKER AS GPR120 AGONISTS | GPR180, GPR68, GPR88 | FFAR1 20/4885FFAR4 42/4885ALOX5 1326/4885 |
| US-10941133-B2 | Compounds containing carbon-carbon linker as GPR120 agonists | GPR180, GPR68, GPR88 | FFAR1 20/4885FFAR4 42/4885ALOX5 1326/4885 |
| US-20210053938-A1 | COMPOUNDS CONTAINING CARBON-CARBON LINKER AS GPR120 AGONISTS | GPR180, GPR68, GPR88 | FFAR1 20/4885FFAR4 42/4885ALOX5 1326/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.